SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-005200
Filing Date
2023-03-31
Accepted
2023-03-31 08:30:34
Documents
69
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blph-20221231x10k.htm   iXBRL 10-K 2140584
2 EX-23.1 blph-20221231xex23d1.htm EX-23.1 2739
3 EX-31.1 blph-20221231xex31d1.htm EX-31.1 12114
4 EX-31.2 blph-20221231xex31d2.htm EX-31.2 12116
5 EX-32 blph-20221231xex32.htm EX-32 11599
6 GRAPHIC blph-20221231x10k003.jpg GRAPHIC 31907
  Complete submission text file 0001558370-23-005200.txt   7680174

Data Files

Seq Description Document Type Size
7 EX-101.SCH blph-20221231.xsd EX-101.SCH 48858
8 EX-101.CAL blph-20221231_cal.xml EX-101.CAL 43588
9 EX-101.DEF blph-20221231_def.xml EX-101.DEF 199660
10 EX-101.LAB blph-20221231_lab.xml EX-101.LAB 440774
11 EX-101.PRE blph-20221231_pre.xml EX-101.PRE 346117
63 EXTRACTED XBRL INSTANCE DOCUMENT blph-20221231x10k_htm.xml XML 1276463
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 23783423
SIC: 2834 Pharmaceutical Preparations